Compare Ev To Free Cash Flow Across Equities
You can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible positions. Check out your portfolio center.
Cross Equities Ev To Free Cash Flow Analysis
Compare X4 Pharmaceuticals, Terns Pharmaceuticals, and Day One Biopharmaceu Ev To Free Cash Flow Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| XFOR | (7.1504) | (7.1504) | (7.1504) | (7.1504) | (7.1504) | (7.1504) | (4.1624) | 1.3703 | 0.4023 | (0.4168) | (1.4762) | (0.2372) | 0.2619 | (1.12) | (1.18) |
| TERN | (19.5642) | (19.5642) | (19.5642) | (19.5642) | (19.5642) | (19.5642) | (19.5642) | (19.5642) | (19.5642) | (6.6923) | (13.1634) | (3.1056) | (4.5518) | (5.6811) | (5.97) |
| DAWN | (316) | (316) | (316) | (316) | (316) | (316) | (316) | (316) | (316) | (316) | (104) | (13.4386) | (12.0509) | (6.2255) | (6.54) |
| PDSB | (19.3503) | (19.3503) | (19.3503) | (19.3503) | (14.6455) | 1.0319 | (8.1933) | (5.3119) | 0.7416 | (0.0409) | (0.5784) | (11.4195) | (12.7253) | (3.601) | (3.78) |
| INZY | (23.6734) | (23.6734) | (23.6734) | (23.6734) | (23.6734) | (23.6734) | (23.6734) | (23.6734) | (23.6734) | (12.3641) | (8.8681) | (2.8985) | (0.2323) | (3.2807) | (3.44) |
| ELEV | (49.5544) | (49.5544) | (49.5544) | (49.5544) | (49.5544) | (49.5544) | (49.5544) | (49.5544) | (49.5544) | (49.5544) | (15.5559) | 0.2183 | (0.0657) | 0.0146 | 0.0153 |
| MREO | (8.7833) | (8.7833) | (8.7833) | (8.7833) | (8.7833) | (8.7833) | (8.7833) | (12.1734) | (19.8031) | (6.7269) | (42.4407) | (133) | (10.5289) | (68.297) | (71.71) |
| HEPA | (3.5 M) | (3.5 M) | (3.5 M) | (8.9957) | (10.858) | (1.2528) | (1.0852) | (2.6701) | (0.143) | 0.2841 | 1.1555 | 0.3476 | 0.8081 | 0.0418 | 0.0439 |
| HOOK | (169) | (169) | (169) | (169) | (169) | (169) | (169) | (169) | (131) | (47.6039) | (3.7546) | (0.2591) | 2.1519 | 0.5507 | 0.58 |
X4 Pharmaceuticals, Terns Pharmaceuticals, and Day One Biopharmaceu Ev To Free Cash Flow description
A valuation metric comparing the company's enterprise value to its free cash flow, used to evaluate whether a company is undervalued or overvalued.Explore Investing Opportunities
You can quickly originate your optimal portfoio using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did you try this?
Run Watchlist Optimization Now
Watchlist OptimizationOptimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
| All Next | Launch Module |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |